The global rivastigmine market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Rivastigmine is a cholinesterase enzyme inhibitor, which acts on butyrylcholinesterase and acetylcholinesterase and it is a cholinergic agent that helps in the treatment of Alzheimer’s and Parkinson’s disease. The drug can be used in the form of transdermal […]
